Keep metabolic research separate from human-use evidence
FDA reports no identified human exposure data for drug products containing MOTs-C and notes peptide-characterization concerns. A metabolic mechanism is not a clinical purchasing authorization.
Documentation to request
Obtain sequence identity and the evidence for the exact material under discussion; distinguish cell or animal work from human safety data.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.